CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis

Glucocorticoid (GC) refractory relapses in patients with multiple sclerosis (MS) or clinically isolated syndrome (CIS), who are in potential need of treatment escalation, are a key challenge in routine clinical practice. The pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlitzki, Marc, Sweeney-Reed, Catherine M., Meuth, Sven G., Reinhold, Dirk, Neumann, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261107/
https://www.ncbi.nlm.nih.gov/pubmed/30475854
http://dx.doi.org/10.1371/journal.pone.0207726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261107/
https://www.ncbi.nlm.nih.gov/pubmed/30475854
http://dx.doi.org/10.1371/journal.pone.0207726

Ejemplares similares